DK1824775T3 - Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf - Google Patents

Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf

Info

Publication number
DK1824775T3
DK1824775T3 DK05804486.8T DK05804486T DK1824775T3 DK 1824775 T3 DK1824775 T3 DK 1824775T3 DK 05804486 T DK05804486 T DK 05804486T DK 1824775 T3 DK1824775 T3 DK 1824775T3
Authority
DK
Denmark
Prior art keywords
bromelain
preparation
methods
debridement composition
debridement
Prior art date
Application number
DK05804486.8T
Other languages
English (en)
Inventor
Marian Gorecki
Amir Toren
Original Assignee
Mediwound Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediwound Ltd filed Critical Mediwound Ltd
Application granted granted Critical
Publication of DK1824775T3 publication Critical patent/DK1824775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05804486.8T 2004-11-22 2005-11-22 Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf DK1824775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL16533404A IL165334A0 (en) 2004-11-22 2004-11-22 Debriding composition from bromelain and methods of producing same
PCT/IL2005/001236 WO2006054309A2 (en) 2004-11-22 2005-11-22 Debriding composition from bromelain

Publications (1)

Publication Number Publication Date
DK1824775T3 true DK1824775T3 (da) 2012-09-24

Family

ID=36407550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05804486.8T DK1824775T3 (da) 2004-11-22 2005-11-22 Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf

Country Status (18)

Country Link
US (2) US8119124B2 (da)
EP (1) EP1824775B1 (da)
JP (1) JP5053096B2 (da)
KR (1) KR101235544B1 (da)
CN (1) CN101297033B (da)
AU (1) AU2005305461B2 (da)
BR (1) BRPI0518050A (da)
CA (1) CA2587951C (da)
DK (1) DK1824775T3 (da)
ES (1) ES2389810T3 (da)
HK (1) HK1124639A1 (da)
IL (2) IL165334A0 (da)
MX (1) MX2007006074A (da)
NO (1) NO337096B1 (da)
PL (1) PL1824775T3 (da)
PT (1) PT1824775E (da)
WO (1) WO2006054309A2 (da)
ZA (1) ZA200704821B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2585104T (pt) * 2010-06-25 2019-10-30 Shire Human Genetic Therapies Métodos e composições de arilsulfatase a para a administração no snc
US20140154235A1 (en) 2011-05-12 2014-06-05 Smith & Nephew Orthopaedics Ag Wound debridement compositions containing seaprose and methods of wound treatment using same
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
RU2625726C2 (ru) 2011-07-20 2017-07-18 Медиваунд Лтд. Экстракт бромелаина с протеолитической активностью для лечения заболеваний соединительных тканей
US10058596B2 (en) * 2011-12-20 2018-08-28 Kci Licensing, Inc. Composition for enzymatic debridement
AU2013259360B2 (en) 2012-05-11 2017-07-13 Smith & Nephew, Inc. Use of Seaprose to remove bacterial biofilm
AU2013344659B2 (en) * 2012-11-14 2017-10-05 Smith & Nephew, Inc. Stable thermolysin hydrogel
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
US20160101166A1 (en) 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
US9592280B2 (en) 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
CN104857187A (zh) * 2015-04-28 2015-08-26 李正 一种菠萝蛋白酶烧伤组织愈合药物
CN108884453B (zh) * 2016-01-31 2022-07-29 麦迪伍德有限公司 用于治疗伤口的清创组合物
EP3445389B1 (en) * 2016-04-18 2022-10-26 Mediwound Ltd Formulations for debridement of chronic wounds
JP7127013B2 (ja) 2016-07-27 2022-08-29 スミス アンド ネフュー インコーポレイテッド 表面から細菌バイオフィルムを低減または除去するためのサーモリシンの使用
CN107913401A (zh) * 2016-10-08 2018-04-17 江阴市本特塞缪森生命科学研究院有限公司 胰蛋白酶产品及治疗妇科炎症的应用
US11413300B2 (en) 2017-01-30 2022-08-16 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
US10799614B2 (en) 2018-10-05 2020-10-13 Xenotherapeutics, Inc. Xenotransplantation products and methods
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
WO2020198397A1 (en) 2019-03-25 2020-10-01 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non- human) donor and methods and products relating to same
US20230255880A1 (en) * 2022-02-16 2023-08-17 Guild Associates Inc. Immobilized enzyme-based wound debridement

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307081A (en) * 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4226854A (en) 1974-01-08 1980-10-07 Gerold K. V. Klein Debridement of devitalized tissue with hydrolytic enzyme product
US4197291A (en) 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
US4329430A (en) * 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4320120A (en) 1979-10-22 1982-03-16 Zenyaku Kogyo Kabushiki Kaisha Extracts of Marsdenia cundurango Reichenbach fil
US4286064A (en) * 1979-11-05 1981-08-25 Riker Laboratories, Inc. Process for isolating active debriding agent from bromelain
US4361551A (en) 1979-11-05 1982-11-30 Riker Laboratories, Inc. Method of enzymatic debridement
JPS56501453A (da) 1979-11-05 1981-10-08
GB8724728D0 (en) 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
CA2046802C (en) 1990-08-15 2007-05-22 Donald Zane Fortney Compositions containing protease produced by vibrio and method of use in debridement and wound healing
WO1993010811A1 (en) 1991-12-03 1993-06-10 Klein Gerold K V Proteolytic mixture containing escharase and method of isolating same
IL103969A (en) * 1991-12-03 1997-01-10 Gerold K V Klein Proteolytic mixture containing escharase and method of isolating same
NZ253748A (en) * 1992-06-30 1997-06-24 Cortecs Ltd Use of enzymes especially proteolytic enzymes in the management or treatment of diarrhoea
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
US5387517A (en) * 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5858964A (en) 1995-04-14 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
US5830793A (en) 1995-12-28 1998-11-03 Micron Technology, Inc. Method of selective texfturing for patterned polysilicon electrodes
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
CN1252101A (zh) * 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
CA2333252C (en) * 1998-07-15 2008-11-25 Ursapharm Arzneimittel Gmbh Use of bromelain proteases for inhibiting blood coagulation
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
US20030026794A1 (en) 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
AU2003262141A1 (en) 2002-04-15 2003-10-27 Sun Pharmaceutical Industries Limited Preperation of desloratatine
ES2393672T3 (es) 2002-04-23 2012-12-27 Mediwound, Ltd. Aparato y procedimientos para su uso en escarotomía enzimática en síndrome de compartimento inducido por quemaduras
WO2008021543A2 (en) * 2006-08-17 2008-02-21 Monsanto Technology, Llc Transgenic plants with enhanced agronomic traits
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions

Also Published As

Publication number Publication date
WO2006054309A3 (en) 2009-04-30
CN101297033A (zh) 2008-10-29
EP1824775A4 (en) 2011-01-26
IL183184A0 (en) 2007-09-20
HK1124639A1 (en) 2009-07-17
JP5053096B2 (ja) 2012-10-17
EP1824775A2 (en) 2007-08-29
PL1824775T3 (pl) 2012-12-31
BRPI0518050A (pt) 2008-10-28
JP2008520651A (ja) 2008-06-19
MX2007006074A (es) 2007-10-04
KR101235544B1 (ko) 2013-02-21
EP1824775B1 (en) 2012-06-13
NO337096B1 (no) 2016-01-18
CN101297033B (zh) 2012-05-30
US20090148429A1 (en) 2009-06-11
NO20073115L (no) 2007-08-13
PT1824775E (pt) 2012-09-19
ES2389810T3 (es) 2012-10-31
AU2005305461B2 (en) 2011-01-27
CA2587951C (en) 2015-03-31
CA2587951A1 (en) 2006-05-26
US8540983B2 (en) 2013-09-24
ZA200704821B (en) 2008-11-26
WO2006054309A2 (en) 2006-05-26
US20120171187A1 (en) 2012-07-05
AU2005305461A1 (en) 2006-05-26
IL183184A (en) 2015-09-24
IL165334A0 (en) 2006-01-15
KR20070091285A (ko) 2007-09-10
US8119124B2 (en) 2012-02-21

Similar Documents

Publication Publication Date Title
DK1824775T3 (da) Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1858488T4 (da) Tigecyclinsammensætninger og fremgangsmåder til fremstilling deraf
DK1965763T3 (da) Stabile enzympræparater og fremgangsmåder til anvendelse heraf
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
HK1110602A1 (en) Compositions and methods of using angiopoietin-like protein
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1729821T3 (da) Sammensætninger og fremgangsmåder til topisk påføring og transdermal afgivelse af botulinumtoksiner
DK1862158T5 (da) Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK1838166T3 (da) Sammensætninger og fremgangsmåder til at forbedre nyrefunktion
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1817055T3 (da) Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
EP1763358A4 (en) COMPOSITIONS AND METHODS CUT-HUNGER
DK1786680T3 (da) Beskyttet hætteglas og fremgangsmåde til fremstilling heraf
DK1928235T3 (da) Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande
DK1783105T3 (da) Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
GB0608398D0 (en) Pharmaceutical composition and method of using same